Rachel Humphrey

Rachel Humphrey is a medical oncologist who is currently serving as the Chief Medical Officer of Black Diamond Therapeutics, and Independent Board Director at Xilio Therapeutics. Among her many prior roles, she has served as both Board Director and as Chief Medical Officer for CytomX. She’s also held various senior level roles in cancer drug development including AstraZeneca (SVP, Head of the Immuno-oncology department), and Bristol Myers Squibb (VP, Clinical Development). Dr. Humphrey’s career is notable for, among other things, overall supervision of the (early and late-stage) clinical development of ipilimumab (Yervoy) at BMS and sorafenib (Nexavar) at Bayer. She is also the lead singer and one of the co-founders of the band, The Checkpoints, a blues band made up of luminaries in immuno-oncology, including the Nobel Laureate, Jim Allison, and is featured in the movie “Jim Allison: Breakthrough”, which was released in the fall of 2019.